1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 48 Hits
  • 検索条件 : 絞込み (MeSH = Immunotherapy)
生物種 リソース名 タイトル
実験動物マウス RBRC09595 Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance.
実験動物マウス RBRC00134 Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.
実験動物マウス RBRC09257 In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.
実験動物マウス RBRC05737 T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control.
実験動物マウス RBRC09256 Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells.
ヒト・動物細胞 MKN7(RCB0999) Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
遺伝子材料 CSII-EF-MCS-IRES2-Venus (RDB04384) , CS-RfA-EG (RDB04391) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy.
ヒト・動物細胞 Colon-26(RCB2657) Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
ヒト・動物細胞 OP9/N-DLL1(RCB2927) Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology.
ヒト・動物細胞 RAW 264(RCB0535) The VIPR2-selective antagonist KS-133 changes macrophage polarization and exerts potent anti-tumor effects as a single agent and in combination with an anti-PD-1 antibody.
ヒト・動物細胞 B16/BL6(RCB2638) Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles.
ヒト・動物細胞 , 遺伝子材料 293T(RCB2202) , LLC(RCB0568) , Colon-26(RCB2657) , CSII-CMV-MCS (RDB04377) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy.
ヒト・動物細胞 B16 Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
ヒト・動物細胞 BALL-1(RCB0256) PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
ヒト・動物細胞 HuH-7 Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma.
ヒト・動物細胞 THP-1 Tumor microenvironment regulation - enhanced radio - immunotherapy.
ヒト・動物細胞 YAC-1(RCB1165) Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
ヒト・動物細胞 RAW 264(RCB0535) Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation.
ヒト・動物細胞 HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Sa3(RCB0980) Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
ヒト・動物細胞 EBC-1(RCB1965) , A549 , HSC-4(RCB1902) , LU65(RCB1967) A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.